The Parkinson’s Disease and Movement Disorders Program offers consultation, expertise and comprehensive care to individuals with neurological movement disorders. Ongoing, long-term care delivered by an interdisciplinary team of specialists provides patients with individualized care and access to the newest developments in treatment. Our multidisciplinary team includes Neurologists who are Movement Disorder Specialists, nurse and rehabilitation specialists. In addition to standard care, patients may choose to participate in the latest clinical trials investigating new medications and therapies for treating Parkinson's disease. The Center offers the most current and innovative medical and surgical treatments for individuals with the following conditions including:
- Parkinson's disease
- Multiple system atrophy (MSA)
- Progressive supranuclear palsy (PSP)
- Huntington's disease
- Restless legs syndrome
We have two locations for outpatient consultation
Boston University Neurology Associates
Boston Medical Center
Shapiro Ambulatory Care Center
725 Albany St., 7th Floor
Boston, MA 02118
Boston University Neurology Associates
541 Main Street, Suite 317
Weymouth, MA 02190
Parkinson's Day Evaluation Program
BMC is pleased to offer patients with Parkinson's disease a Day Evaluation Program designed to take the traditional clinic visit a step further by extending the observation and assessment phase of treatment.
Based on the belief that learning more about each person’s condition will facilitate a healthy adjustment and assure more effective management of the disease, there are two types of patient programs available:
- Extended Observation and Assessment
- Newly Diagnosed Patient and Family
In addition to physician and nurse observation, the program’s activities focus on the many aspects of coping with Parkinson's disease and may include teaching, discussions, exercise demonstrations, counseling, and emotional support services.
Deep Brain Stimulation Program
The Deep Brain Stimulation (DBS) Program is a collaborative medical and surgical program for the treatment of Parkinson's disease, essential tremor, and dystonia. This multidisciplinary program includes neurosurgery, neurology, neuropsychiatry, behavioral medicine, anesthesiology, and nursing to care for patients.
A multi-step screening process is used to select patients carefully for this procedure. Some patients who may be candidates for surgery include: 1) patients who do not have good movement control despite optimized medical therapy and 2) patients who have dyskinesia or other side effects that limit the use of Parkinson's medications.
In the selection process, patients are referred by their neurologist for a screening neurological consultation by the neurological DBS program director, Samuel Ellias, MD or associate director Okeanis Vaou, MD. Patients are evaluated with a brain MRI, neuropsychological testing, and movement testing with videotaping. Test results are reviewed by a panel of movement disorder specialists before referring the patient to the neurosurgeon for further evaluation. The patient is then seen and evaluated by the DBS neurosurgical director, Keith Davies, MD.
After DBS, patients receive follow-up neurological care and adjustments of medications and DBS neurostimulators.
Clinical Research Program
The Parkinson Disease and Movement Disorders Center at Boston University Medical Campus has a long established clinical research program. Research is ongoing and includes observational and interventional research in pharmacology and rehabilitation.
Clinical research staff includes neurologists with specialty training in movement disorders, nurse specialists, and research assistants. Staff are members of the Parkinson Study Group and Huntington’s Study Group. The Center is designated an American Parkinson Disease Association Center for Advanced Research.
There are several ongoing research opportunities. For information, please contact Ray James, RN at (617) 638-7745 or Christine Tran at (617) 638-7747. Listed below are trials currently recruiting subjects. Institutional Review Board approval has been obtained to publicize these trials.
- Evaluation of the Accordion Pill in Individuals with Fluctuating Parkinson’s Disease (Accordance Study)
- A Randomized, Double-Blinded, Placebo-Controlled Trial of Urate-Elevating Inosine Treatment to Slow Clinical Decline in Early Parkinson’s Disease (SURE-PD3)
- Study on Inhalable Parkinson’s Disease Medication – Ongoing Enrollment Complete
- Biomarker Study (MICRO-PD)
- Parkinson’s Progression Markers Initiative Study- Genetic Cohort (PPMI2)
- Effects of Parkinson’s Disease on Perception, Cognition and Gait
- Parkinson’s Progression Markers Initiative Study (PPMI) – Ongoing Enrollment Complete
- Social Self-Management in Parkinson’s Disease – Ongoing Enrollment Complete
Patient Education and Support
American Parkinson’s Disease Association Information & Referral Center
The Information & Referral Center was established at BMC in 1980.
The Center serves as a resource for those with Parkinson's disease and their loved ones, as well as healthcare providers. Patients, caregivers, healthcare providers, and the greater community can receive support regardless of their affiliation with the hospital. Services include:
- A telephone helpline, (617) 638-8466 or (800) 651-8466
- A comprehensive resource referral network
- Support group assistance
- Counseling and guidance
- Training and support for healthcare professionals
- Implementation of regional conferences
- Participation in community awareness and public relations activities
- Maintaining an informational website
For information or to make an appointment, call the APDA Information & Referral Center at (617) 638-8466 or (800) 651-8466.